Commission Implementing Decision (EU) 2021/260 of 11 February 2021 approving national measures designed to limit the impact of certain diseases of aquatic animals in accordance with Article 226(3) of Regulation (EU) 2016/429 of the European Parliament and of the Council and repealing Commission Decision 2010/221/EU (notified under document C(2021) 773) (Text with EEA relevance)
Commission Implementing Decision (EU) 2021/260 of 11 February 2021 approving national measures designed to limit the impact of certain diseases of aquatic animals in accordance with Article 226(3) of Regulation (EU) 2016/429 of the European Parliament and of the Council and repealing Commission Decision 2010/221/EU (notified under document C(2021) 773) (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
This Decision approves the national measures which have been adopted by those Member States or parts of those Member States which are listed in Annexes I and II in order to limit the impact of certain diseases affecting aquatic animals in accordance with Article 226(3) of Regulation (EU) 2016/429, and lays down:
(a)
conditions for the initial and continued approval of those measures;
(b)
restrictions on the movement of aquatic animals between Member States;
(c)
reporting obligations of Member States.
Approval of national measures in disease-free areas
The Member States or parts thereof, which are listed in the second and fourth column of the table in Annex I, are considered free from the diseases listed in the first column of that table and are granted approval to adopt national measures in accordance with Article 226(3) of Regulation (EU) 2016/429.
Approval of eradication programmes for diseases which are subject to national measures
1. The eradication programmes adopted by the Member States listed in the second column of the table in Annex II for the diseases which are subject to national measures and which are listed in the first column of that table, in respect of the areas listed in the fourth column thereof, are approved.
2. The period of application of an eradication programme shall not exceed 6 years from the date of its initial approval by the Commission. In duly justified cases, the Commission may, at the request of the Member State concerned, extend the period of application of the eradication programme for an additional 6-year period.
Movements between Member States or parts thereof, of aquatic animals of susceptible species which are subject to national measures including eradication programmes
Aquatic animals of species susceptible to the diseases set out in the second column of Annex III shall only be moved to Member States or parts thereof which are listed in the second and fourth column of the tables in Annexes I or II if they:
(a)
originate from a Member State or part thereof, which is listed in the second and fourth column of the table in Annex I as being free from the disease in question; and
(b)
are accompanied by an official certificate issued by the competent authority of the Member State of origin, drawn up in accordance with an appropriate model animal health certificate set out in Chapters 1, 2, 3 or 5 of Annex I to Implementing Regulation (EU) 2020/2236, specifying the guarantees relevant for the specific national measures in question.
1. By 30 April each year at the latest, the Member States listed in the second column of the tables in Annexes I and II shall submit a report to the Commission on the approved national measures for the disease-free status of those Member States and parts thereof referred to in Article 2, or for the eradication programmes referred to in Article 3, as appropriate.
2. The report referred to in paragraph 1 shall include:
(a)
information on the measures which have been taken in the previous calendar year to maintain the disease-free status, including at least the information set out in Annex III to Implementing Regulation (EU) 2020/2002; or
(b)
information on the evolution of the eradication programme, including details of the testing which has been carried out in the previous calendar year and at least the information set out in Section 4 of Annex V to Implementing Regulation (EU) 2020/2002.
3. The report referred to in paragraph 1 shall outline the reasons why the disease-free status or the eradication programme as appropriate, should continue to apply for a further calendar year. Particular reference shall be made to the availability of treatments, vaccines, disease resistant stocks, or other relevant developments should one or more of these have become a viable option for the prevention and control of the disease in question since the submission of the previous report.
The national measures set out in Annexes I and II may be amended by the Commission should the information referred to in Article 5(3), or other such information relating to developments in animal health, indicate that the establishment of movement restrictions between Member States is no longer necessary or justified in order to prevent the introduction, or to control the spread, of a particular disease.
Member States ( 1 ) or parts thereof regarded as being free from certain diseases affecting aquatic animals and for which the national measures are approved in accordance with Article 226(3) of Regulation (EU) 2016/429
ANNEX I
Member States ( 1 ) or parts thereof regarded as being free from certain diseases affecting aquatic animals and for which the national measures are approved in accordance with Article 226(3) of Regulation (EU) 2016/429
Disease
Member State
Code
Geographical demarcation of the area for which the national measures are approved
Koi herpes virus disease (KHV)
Ireland
IE
Whole territory
United Kingdom (Northern Ireland)
UK(NI)
Northern Ireland
Spring viraemia of carp (SVC)
Denmark
DK
Whole territory
Finland
FI
Whole territory
Hungary
HU
Whole territory
Ireland
IE
Whole territory
Sweden
SE
Whole territory
United Kingdom (Northern Ireland)
UK(NI)
Northern Ireland
Bacterial kidney disease (BKD)
Ireland
IE
Whole territory
United Kingdom (Northern Ireland)
UK(NI)
Northern Ireland
Infectious pancreatic necrosis (IPN)
Finland
FI
Continental parts of the territory
Sweden
SE
Continental parts of the territory
Infection with Gyrodactylus salaris (GS)
Finland
FI
Water catchment areas of the Tenojoki and Näätämöjoki; the water catchment areas of the Paatsjoki, Tuulomajoki, and Uutuanjoki are considered as buffer zones
Ireland
IE
Whole territory
United Kingdom (Northern Ireland)
UK(NI)
Northern Ireland
Ostreid herpesvirus – 1 μvar (OsHV-1 μvar)
Ireland
IE
Compartment 1: Sheephaven Bay
Compartment 3: Killala, Broadhaven and Blacksod Bays
Compartment4: Streamstown Bay Compartment 5: Bertraghboy and Galway Bays
Compartment A: Tralee Bay Hatchery
United Kingdom (Northern Ireland)
UK(NI)
Territory of Northern Ireland except Dundrum Bay, Killough Bay, Lough Foyle, Carlingford Lough, Larne Lough and Strangford Lough
Infection with salmonid alphavirus (SAV)
Finland
FI
Continental parts of the territory
( 1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex, references to Member States include the United Kingdom in respect of Northern Ireland.
Member States ( 1 ) or parts thereof with eradication programmes for certain diseases affecting aquatic animals and for which the national measures are approved in accordance with Article 226(3) of Regulation (EU) 2016/429
ANNEX II
Member States ( 1 ) or parts thereof with eradication programmes for certain diseases affecting aquatic animals and for which the national measures are approved in accordance with Article 226(3) of Regulation (EU) 2016/429
Disease
Member State
Code
Geographical demarcation of the area for which the national measures are approved
Bacterial kidney disease (BKD)
Sweden
SE
Continental parts of the territory
Infectious pancreatic necrosis (IPN)
Sweden
SE
Coastal parts of the territory
( 1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex, references to Member States include the United Kingdom in respect of Northern Ireland.
Species of aquatic animals which are susceptible to diseases for which certain Member States ( 1 ) have adopted national measures in accordance with Article 226(3) of Regulation (EU) 2016/429
ANNEX III
Species of aquatic animals which are susceptible to diseases for which certain Member States ( 1 ) have adopted national measures in accordance with Article 226(3) of Regulation (EU) 2016/429
Disease
Susceptible species
Koi herpes virus disease (KHV)
As set out in column 3 of the table in the Annex to Implementing Regulation (EU) 2018/1882
Spring viraemia of carp (SVC)
Bighead carp ( Aristichthys nobilis ), goldfish ( Carassius auratus ), crucian carp ( Carassius carassius ), grass carp ( Ctenopharyngodon idellus ), common carp and koi carp ( Cyprinus carpio ), silver carp ( Hypophthalmichthys molitrix ), sheatfish ( Silurus glanis ), tench ( Tinca tinca ), orfe ( Leuciscus idus )
Bacterial kidney disease (BKD)
All species of Salmonidae
Infectious pancreatic necrosis (IPN)
Brook trout ( Salvelinus fontinalis ), brown trout ( Salmo trutta ), Atlantic salmon ( Salmo salar ), ( Oncorhynchus spp. ) whitefish ( Coregonus lavaretus)
Infection with Gyrodactylus salaris (GS)
Atlantic salmon ( Salmo salar ), rainbow trout ( Oncorhynchus mykiss ), Arctic char ( Salvelinus alpinus ), North American brook trout ( Salvelinus fontinalis ), grayling ( Thymallus thymallus ), North American lake trout ( Salvelinus namaycush ), brown trout ( Salmo trutta ) and any species which has been in contact with these species
Ostreid herpes virus 1 μvar (OsHV-1 μvar)
Pacific oyster ( Crassostrea gigas )
Infection with salmonid alphavirus (SAV)
Atlantic salmon ( Salmo salar ), rainbow trout ( Oncorhynchus mykiss ), brown trout ( Salmo trutta )
( 1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex, references to Member States include the United Kingdom in respect of Northern Ireland.
